These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31623253)

  • 1. Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin.
    Shlezinger M; Coppenhagen-Glazer S; Gelman D; Beyth N; Hazan R
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31623253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of oritavancin against planktonic and biofilm states of vancomycin-susceptible and vancomycin-resistant enterococci.
    Yan Q; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):348-350. PubMed ID: 29678300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown Gandt A; Griffith EC; Lister IM; Billings LL; Han A; Tangallapally R; Zhao Y; Singh AP; Lee RE; LaFleur MD
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel high-resolution melting analysis approach for rapid detection of vancomycin-resistant enterococci.
    Ozbak HA
    Ann Saudi Med; 2018; 38(3):200-207. PubMed ID: 29848938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totarol exhibits antibacterial effects through antibiofilm and combined interaction against vancomycin-resistant
    Hyeon GE; Eom YB
    Can J Microbiol; 2024 Oct; 70(10):426-432. PubMed ID: 39058360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agricultural Origins of a Highly Persistent Lineage of Vancomycin-Resistant
    Rushton-Green R; Darnell RL; Taiaroa G; Carter GP; Cook GM; Morgan XC
    Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31028029
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018.
    Zhou W; Zhou H; Sun Y; Gao S; Zhang Y; Cao X; Zhang Z; Shen H; Zhang C
    BMC Infect Dis; 2020 May; 20(1):356. PubMed ID: 32517758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
    J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.
    AbdelKhalek A; Abutaleb NS; Elmagarmid KA; Seleem MN
    Sci Rep; 2018 May; 8(1):8353. PubMed ID: 29844350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.
    Honsa ES; Cooper VS; Mhaissen MN; Frank M; Shaker J; Iverson A; Rubnitz J; Hayden RT; Lee RE; Rock CO; Tuomanen EI; Wolf J; Rosch JW
    mBio; 2017 Jan; 8(1):. PubMed ID: 28049149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors of methicillin-resistant
    Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
    Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms.
    Zhang H; Zhang X; Liang S; Wang J; Zhu Y; Zhang W; Liu S; Schwarz S; Xie F
    NPJ Biofilms Microbiomes; 2023 Apr; 9(1):16. PubMed ID: 37024490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms.
    Tinoco JM; Buttaro B; Zhang H; Liss N; Sassone L; Stevens R
    Arch Oral Biol; 2016 Nov; 71():80-86. PubMed ID: 27448990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defeating Antibiotic- and Phage-Resistant
    Khalifa L; Gelman D; Shlezinger M; Dessal AL; Coppenhagen-Glazer S; Beyth N; Hazan R
    Front Microbiol; 2018; 9():326. PubMed ID: 29541067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin resistance reversal in enterococci by flavonoids.
    Liu LX; Durham DG; Richards RM
    J Pharm Pharmacol; 2001 Jan; 53(1):129-32. PubMed ID: 11206187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of an FtsZ Inhibitor Celastrol and Its Synergistic Effect with Vancomycin against Enterococci
    Lu X; Wang Y; Guo W; Zhang Z; Hu X; Nie T; Yang X; Li C; Wang X; Li X; Lu Y; Li G; Zhang Y; Sun L; Pang J; You X
    Microbiol Spectr; 2023 Feb; 11(1):e0369922. PubMed ID: 36622182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.
    Chatterjee A; Johnson CN; Luong P; Hullahalli K; McBride SW; Schubert AM; Palmer KL; Carlson PE; Duerkop BA
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.